These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32817485)

  • 1. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
    Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
    Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
    J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
    Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
    Gutierrez IV; Dayton J; Harger S; Rossetto CC
    J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of TRIM32 is induced by RTA for Kaposi's sarcoma-associated herpesvirus lytic replication.
    Zhang Y; Dong Z; Gu F; Xu Y; Li Y; Sun W; Rao W; Du S; Zhu C; Wang Y; Wei F; Cai Q
    J Virol; 2024 Jun; 98(6):e0000524. PubMed ID: 38717113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RNA quality control pathway nonsense-mediated mRNA decay targets cellular and viral RNAs to restrict KSHV.
    Zhao Y; Ye X; Shehata M; Dunker W; Xie Z; Karijolich J
    Nat Commun; 2020 Jul; 11(1):3345. PubMed ID: 32620802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.
    Lee HR; Doğanay S; Chung B; Toth Z; Brulois K; Lee S; Kanketayeva Z; Feng P; Ha T; Jung JU
    J Virol; 2014 Feb; 88(4):2183-94. PubMed ID: 24335298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of KSHV Latency and Lytic Reactivation.
    Broussard G; Damania B
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
    Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.
    Lai IY; Farrell PJ; Kellam P
    J Gen Virol; 2011 Feb; 92(Pt 2):421-31. PubMed ID: 20980528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.